Antibodies.com and Cactus Communications partner to accelerate life science manuscript publication
Partnership provides Antibodies.com’s network of scientists with access to CACTUS’ editorial and publishing services to improve manuscript quality and increase publication success
Cambridge, UK, and Mumbai, India: Antibodies.com, a trusted provider of high-quality biological reagents for life science researchers, and Cactus Communications (CACTUS), a global leader in science communication and technology, today announced a partnership to support effective science communications. The collaboration aims to simplify the journey from discovery to publication by providing essential tools for high-quality, impactful research, driving innovation and accelerating advancements in the life sciences.
The partnership will bring CACTUS’ expertise in academic publishing to Antibodies.com’s extensive network of over 30,000 scientists. Through Editage, CACTUS’ flagship brand, researchers will have access to a suite of writing and editing tools, including English language editing, article promotion, and rapid statistical review, streamlining manuscript preparation and boosting publication prospects.
Nikesh Gosalia, President of Global Academic and Publisher Relations at CACTUS, said: “Researchers face significant challenges in the publication process. At CACTUS, we strive to ease this journey by supporting scientists from the early stages of research communication to producing impactful, globally recognized work. Our partnership with Antibodies.com underscores our shared dedication to enhancing research quality, enabling us to deliver tailored end-to-end solutions that enhance scientific discovery and dissemination”
Stewart Newlove, CTO and Co-Founder, Antibodies.com, added: “This partnership represents a strategic step in delivering more value to researchers. By integrating world-class editorial and publishing services into our existing offerings, we aim to support researchers at every stage of their journey; not only with high-quality biological reagents, but also the tools for manuscript preparation and publication. Through this collaboration, we are making the publication process more accessible and efficient, helping to improve manuscript quality, increase publication success, and ultimately accelerate scientific advancements.”
Customers of Antibodies.com receive a special offering for exclusive editorial and publishing services through Cactus by visiting https://authorservices.antibodies.com/ or www.antibodies.com.
Notes to editors:
Nikesh Gosalia, President of Global Academic and Publisher Relations, CACTUS | Stewart Newlove, CTO and Co-Founder, Antibodies.com |
About Antibodies.com www.antibodies.com
At Antibodies.com, we specialise in providing high-quality antibodies and biological reagents to accelerate life science research. With a catalogue of over 100,000 products, including primary and secondary antibodies, proteins, and ELISA kits, we are committed to delivering the tools researchers need to drive groundbreaking discoveries. Headquartered in Cambridge, UK, with offices in Stockholm and St. Louis, we serve scientists in over 100 countries, offering expert support, in-depth product datasheets, and rapid global delivery – all at unbeatable prices. Trust Antibodies.com to power your research with precision and excellence.
About Cactus Communications www.cactusglobal.com
Cactus Communications is a leading provider of communication solutions, including academic and scientific editing, medical communications, publication support services, English-language workshops, transcription, and translation. Our company mission is to enable growth through effective communication.
CACTUS offers services to two key client segments worldwide: Academia (researchers, scholarly journals and publishers, universities, and academic societies) and Pharmaceutical and Device companies. With offices in the US, Japan, India, South Korea, Singapore and China, CACTUS has processed more than 690,000 documents from 179,000 clients across 164+ countries in the last 14 years.